SMARCE1 Gene Meningioma Familial Susceptibility to NGS Genetic DNA Test
Introduction
The SMARCE1 Gene Meningioma Familial Susceptibility to NGS Genetic DNA Test is a cutting-edge genetic test that assesses the presence of mutations in the SMARCE1 gene, which is associated with an increased risk of developing meningiomas, a type of brain tumor. This test is crucial for individuals with a family history of meningioma, as it provides valuable insights into their genetic predisposition to this condition.
What the Test Measures
This test detects mutations in the SMARCE1 gene using Next Generation Sequencing (NGS) technology. By analyzing the genetic material, the test identifies any hereditary factors that may contribute to the development of meningiomas, allowing for proactive monitoring and management.
Who Should Consider This Test
Individuals who have a family history of meningioma or related symptoms should consider this test. Risk factors include:
- Multiple family members diagnosed with meningioma.
- Personal history of brain tumors.
- Symptoms such as headaches, vision changes, or seizures.
Benefits of Taking the Test
- Identifies genetic predispositions to meningioma.
- Enables early intervention and tailored management strategies.
- Provides peace of mind for individuals with a family history of the disease.
- Facilitates informed decision-making regarding health and lifestyle choices.
Understanding Your Results
After the test, results will be provided, indicating whether any mutations were detected. A genetic counseling session is recommended to help interpret the results and discuss potential next steps, including monitoring or preventive measures.
Test Name and Price
| Test Name | Discount Price (KSh) | Regular Price (KSh) |
|---|---|---|
| SMARCE1 Gene Meningioma Familial Susceptibility to NGS Genetic DNA Test | 40,000 | 56,000 |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood, extracted DNA, or even one drop of blood on an FTA card. Prior to testing, a clinical history of the patient is necessary, along with a genetic counseling session to create a pedigree chart of affected family members.
Book Your Test Today!
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu, and offer home sample collection services for your convenience. To book the SMARCE1 Gene Meningioma Familial Susceptibility to NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.
